Sagent Pharmaceuticals, Inc
UnclaimedPharmaceutical Preparation ManufacturingSchaumburg, IL
Founded
2006
Primary NAICS
325412
CAGE code
4RP13
Federal awards
$65.9M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Medicinal and Botanical ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $275,580 | 2 |
| 2026 | Department of Defense | $150,969 | 46 |
| 2025 | Department of Health and Human Services | $16,638,758 | 1 |
| 2025 | Department of Defense | $102,638 | 32 |
| 2025 | Department of Veterans Affairs | $0 | 3 |
| 2024 | Department of Defense | $220,120 | 29 |
| 2024 | Department of Health and Human Services | $0 | 2 |
| 2024 | Department of Veterans Affairs | $0 | 2 |
| 2023 | Department of Defense | $189,719 | 49 |
| 2023 | Department of Veterans Affairs | $0 | 2 |
| 2023 | Department of Health and Human Services | $0 | 2 |
| 2022 | Department of Health and Human Services | $47,750,653 | 1 |
| 2022 | Department of Defense | $581,852 | 29 |
| 2022 | Department of Veterans Affairs | $0 | 7 |